Neucyte
UEI: X263NRWQNLL6
• CAGE: 7JNY8
Overview
Awardee Type
Parent
Company Description
NeuCyte is a biotech company focused on CNS drug discovery. Its SynFire® technology uses human iPSC-derived neurons to identify drug targets, test efficacy, and assess neurotoxicity. We are actively pursuing drug discovery programs for Alzheimer's, ALS, Epilepsy, Fragile X Syndrome, and more.
Keywords
Cell provider, CRO, pharma, drug discovery
Name
Neucyte
Website
Headquarters
Mountain View, CA
United States
United States
Most Recent Award
Sept. 15, 2024
Calculating
Federal contract and grant recipient
NEUCYTE INC
(UEI X263NRWQNLL6, CAGE 7JNY8)
is headquartered in Mountain View CA.
Its primary registered NAICS is 325414 Biological Product (except Diagnostic) Manufacturing.
The corporation
was founded in November 2015 and
federally registered in
January 2016.
Federal Award Analysis
Neucyte federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
NEUCYTE INC
UEI
X263NRWQNLL6
CAGE Code
7JNY8
SBA Certifications
None
Self Certifications
Asian-Pacific American Owned
Minority Owned Business
Minority Owned Business
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
Nov. 4, 2015
Initial Registration
Jan. 14, 2016
Last Registration
Aug. 26, 2024
Registration Activation
Aug. 23, 2024
Registration Expiration
Aug. 20, 2025
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
State of Incorporation
DE
Country of Incorporation
USA
Employees
<500
Reported NAICS
Accepts Credit Cards
Yes